This article from the March 2018 issue of the European Respiratory Journal was originally published with errors in the stated concentrations of anti-tuberculosis drugs used in the drug susceptibility testing for the study.
The sentence that originally stated:
“Phenotypic DST was also performed on all culture isolates on solid Löwenstein–Jensen media for levofloxacin at 1.0 µg·mL−1 and SLI agents at the following concentrations: 30 µg·mL−1 for kanamycin, and 40 µg·mL−1 for amikacin and capreomycin.”
Should be amended to state:
“Phenotypic DST was also performed on all culture isolates on liquid DST (MGIT960) for levofloxacin at 1.5 µg·mL−1 and SLI agents at the following concentrations: 2.5 µg·mL−1 for kanamycin and capreomycin, and 1.0 µg·mL−1 for amikacin.”
The original article has been corrected and republished online.
- Copyright ©ERS 2018